- Home
- Publications
- Publication Search
- Publication Details
Title
Effectiveness of the Coronavirus Disease 2019 Bivalent Vaccine
Authors
Keywords
-
Journal
Open Forum Infectious Diseases
Volume 10, Issue 6, Pages -
Publisher
Oxford University Press (OUP)
Online
2023-04-20
DOI
10.1093/ofid/ofad209
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Necessity of Coronavirus Disease 2019 (COVID-19) Vaccination in Persons Who Have Already Had COVID-19
- (2022) Nabin K Shrestha et al. CLINICAL INFECTIOUS DISEASES
- Protection against the Omicron Variant from Previous SARS-CoV-2 Infection
- (2022) Heba N. Altarawneh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genomic Surveillance for SARS-CoV-2 Variants: Predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) Variants — United States, June 2021–January 2022
- (2022) Anastasia S. Lambrou et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Coronavirus Disease 2019 (COVID-19) Vaccine Boosting in Previously Infected or Vaccinated Individuals
- (2022) Nabin K. Shrestha et al. CLINICAL INFECTIOUS DISEASES
- Seroprevalence of Infection-Induced SARS-CoV-2 Antibodies — United States, September 2021–February 2022
- (2022) Kristie E.N. Clarke et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Protection of COVID-19 vaccination and previous infection against Omicron BA.1, BA.2 and Delta SARS-CoV-2 infections
- (2022) Stijn P. Andeweg et al. Nature Communications
- Percentage of Asymptomatic Infections among SARS-CoV-2 Omicron Variant-Positive Individuals: A Systematic Review and Meta-Analysis
- (2022) Weijing Shang et al. Vaccines
- Rate of SARS-CoV-2 Reinfection During an Omicron Wave in Iceland
- (2022) Elias Eythorsson et al. JAMA Network Open
- Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022
- (2022) Ruth Link-Gelles et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination
- (2022) Pascal Irrgang et al. Science Immunology
- The Proportion of SARS-CoV-2 Infections That Are Asymptomatic
- (2021) Daniel P. Oran et al. ANNALS OF INTERNAL MEDICINE
- BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
- (2021) Noa Dagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data
- (2021) Eric J Haas et al. LANCET
- Estimating the asymptomatic proportion of SARS-CoV-2 infection in the general population: Analysis of nationwide serosurvey data in the Netherlands
- (2021) Scott A. McDonald et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started